SOST and osteoporosis: The FDA has approved various medications for the treatment of osteoporosis, including antiresorptive agent bisphosphonates, estrogen-related therapies, parathyroid hormone analogs, denosumab, a RANKL inhibitor, and romosozumab, a sclerostin inhibitor [3].